(0.16%) 5 139.50 points
(0.09%) 38 475 points
(0.26%) 17 893 points
(-0.04%) $83.82
(1.09%) $1.944
(0.22%) $2 352.30
(0.56%) $27.69
(2.02%) $940.70
(-0.21%) $0.933
(-0.28%) $10.99
(-0.35%) $0.798
(1.29%) $93.06
Live Chart Being Loaded With Signals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular...
Stats | |
---|---|
今日成交量 | 8.77M |
平均成交量 | 6.57M |
市值 | 107.55B |
EPS | $0 ( 2024-04-24 ) |
下一个收益日期 | ( $0.580 ) 2024-07-25 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.49 |
ATR14 | $0.0320 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Sorenson John Bradley | Buy | 16 351 | Common Stock |
2024-04-01 | Sorenson John Bradley | Sell | 16 351 | Common Stock |
2024-04-01 | Sorenson John Bradley | Sell | 16 351 | Stock Option (Right to Buy) |
2024-04-01 | Carruthers Wendy | Buy | 1 197 | Common Stock |
2024-04-01 | Carruthers Wendy | Buy | 3 066 | Common Stock |
INSIDER POWER |
---|
-44.36 |
Last 100 transactions |
Buy: 127 379 | Sell: 329 771 |
音量 相关性
Boston Scientific Corp 相关性 - 货币/商品
Boston Scientific Corp 财务报表
Annual | 2023 |
营收: | $14.24B |
毛利润: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2023 |
营收: | $14.24B |
毛利润: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2022 |
营收: | $12.68B |
毛利润: | $8.68B (68.44 %) |
EPS: | $0.450 |
FY | 2021 |
营收: | $11.89B |
毛利润: | $8.13B (68.37 %) |
EPS: | $0.730 |
Financial Reports:
No articles found.
Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。